HER2 Positive Early Stage Breast Cancer - The Breast Cancer Trials Podcast

Episode 39: Breast Cancer Clinical Trials and Overcoming Barriers to AccessПодробнее

Managing Central Nervous System Metastasis in Patients With HER2-Positive Breast CancerПодробнее

02_08 Early HER-2 positive breast cancerПодробнее

02_07 HER-2 positive breast cancer: Considerations in advanced diseaseПодробнее

Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancerПодробнее

Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12Подробнее

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and ToxicityПодробнее

Evolving Conversations in HER2+ Oligometastatic Breast Cancer ManagementПодробнее

Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika HamiltonПодробнее

Research Highlights from the 2021 San Antonio Breast Cancer Symposium, with Norah Lynn Henry, MD,...Подробнее

Getting to the Heart of the Matter: Biomarkers for the Assessment of Trastuzumab-Induced Cardiac ...Подробнее

HERA Indicates that Adjuvant Trastuzumab Confers Equal Benefit for HER2-Positive Invasive Ductal ...Подробнее

Treatment Progress in Triple Negative Breast Cancer – Improving Disparities and Outcomes with New...Подробнее

2023 Research Round Up: Breast Cancer, Lymphoma, Multiple Myeloma, and Brain TumorsПодробнее

Research Highlights from the 2019 San Antonio Breast Cancer Symposium, with Norah Lynn Henry, MD,...Подробнее

Research Highlights from the 2022 San Antonio Breast Cancer Symposium, with Norah Lynn Henry, MD,...Подробнее

JCO Article Insights: Elderly Patients Receiving Chemotherapy for Early-Stage Breast CancerПодробнее

Who Needs What Therapy? The Elusive Search for Predictive MarkersПодробнее

ASCO20 Virtual Scientific Program Research Round Up: Breast Cancer, Sarcoma, and Supportive CareПодробнее

2019 ASCO Annual Meeting Research Round Up: Breast Cancer, Head and Neck Cancer, and Cancer-Relat...Подробнее